Insurance status and pediatric mortality in nonaccidental trauma

Kristin A Sonderman1, Lindsey L Wolf1, Arin L Madenci2

  • 1Center for Surgery and Public Health, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Insights

Uninsured children experiencing nonaccidental trauma (NAT) face significantly higher mortality risks. This highlights the vulnerability of uninsured pediatric patients and the need for targeted interventions to improve outcomes in cases of child abuse.

Area of Science:

  • Pediatric Trauma
  • Public Health
  • Health Disparities

Background:

  • Nonaccidental trauma (NAT) is a critical cause of mortality in young children.
  • Understanding factors influencing outcomes in pediatric NAT is essential for effective intervention.
  • Insurance status is a potential determinant of mortality in pediatric NAT cases.

Purpose of the Study:

  • To investigate the association between insurance status and mortality in pediatric patients hospitalized with nonaccidental trauma.
  • To identify specific patient characteristics and injury factors associated with increased mortality in NAT.
  • To determine if insurance status independently impacts the odds of death among pediatric NAT patients.

Main Methods:

  • Retrospective cohort study utilizing the 2012-2014 National Trauma Databank.
  • Inclusion criteria: children (≤18 years) hospitalized with NAT (ICD-9 codes E967-968).
  • Primary exposure: insurance status (public, private, uninsured); primary outcome: mortality.

Main Results:

  • A total of 6389 pediatric NAT patients were identified; 8% died.
  • Uninsured patients (6%) had higher mortality rates (13%) compared to publicly insured (77%) and privately insured (17%) patients.
  • After adjusting for confounders, uninsured children had 3.3-fold greater odds of death compared to publicly insured children. Increased Injury Severity Score (ISS) also correlated with higher mortality.

Conclusions:

  • Uninsured pediatric patients with nonaccidental trauma exhibit significantly increased odds of mortality.
  • This finding underscores the vulnerability of uninsured children in the context of severe injury and abuse.
  • Targeted interventions are crucial for this population to mitigate adverse outcomes.
Abstract

Related Concept Videos

Marcia's Theory of Identity Status01:26

Marcia's Theory of Identity Status

James Marcia's identity status model provides a framework for understanding how adolescents navigate identity formation through varying degrees of exploration and commitment. Marcia's model builds on Erik Erikson's theories of psychosocial development, focusing specifically on how adolescents reconcile individual aspirations with societal expectations. His model describes identity formation as a dynamic process where adolescents move between different states depending on their level...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
264
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
311
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
233
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
301
Cross-Sectional Research01:50

Cross-Sectional Research

In cross-sectional research, a researcher compares multiple segments of the population at the same time. If they were interested in people's dietary habits, the researcher might directly compare different groups of people by age. Instead of following a group of people for 20 years to see how their dietary habits changed from decade to decade, the researcher would study a group of 20-year-old individuals and compare them to a group of 30-year-old individuals and a group of 40-year-old...
12.5K